A pooled analysis of the data from the 3 pivotal trials showed reductions in A1C and LDL-C when Welchol was added to metformin-based, sulfonylurea-based, and insulin-based therapies in patients with type 2 diabetes. In these studies….
Link to download (.ppt format): Cost-Effectiveness Strategies, Part 4 of 4
Other sets in this series:
Check out all of Diabetes In Control’s slide collections at our new Clinical Presentations Library.